FVB;129P2-Cdkn2atm2Brn/Cnrm

Status

Available to order

EMMA IDEM:00407
International strain nameFVB;129P2-Cdkn2atm2Brn/Cnrm
Alternative nameI4aF
Strain typeTargeted Mutant Strains : Conditional mutation
Allele/Transgene symbolCdkn2atm2Brn
Gene/Transgene symbolCdkn2a

Information from provider

ProviderAnton Berns
Provider affiliationResearch - Animal Facility, The Netherlands Cancer Institute
Genetic informationExons 2 and 3 are flanked by loxP sites.
Phenotypic informationConditional p16ink4a and p19Arf knock-out, no phenotype
References
  • Loss of p16Ink4a confers susceptibility to metastatic melanoma in mice.;Krimpenfort P, Quon K C, Mooi W J, Loonstra A, Berns A, ;2001;Nature;413;83-6; 11544530

Information from EMMA

Archiving centreCNR, Consiglio Nazionale delle Ricerche, Monterotondo, Italy

Disease and phenotype information

IMPC phenotypes (gene matching)
  • cataract / IMPC
  • abnormal lens morphology / IMPC
  • developmental and structural abnormality / IMPC
  • abnormal eye morphology / IMPC
  • cyst / IMPC
  • process of degenerative change / IMPC
MGI phenotypes (gene matching)
  • extramedullary hematopoiesis / MGI
  • abnormal spleen morphology / MGI
  • thymus hyperplasia / MGI
  • hindlimb paralysis / MGI
  • abnormal retinal photoreceptor morphology / MGI
  • increased metastatic potential / MGI
  • microphthalmia / MGI
  • abnormal lens morphology / MGI
  • cataract / MGI
  • abnormal retina morphology / MGI
  • male infertility / MGI
  • blindness / MGI
  • neoplasm / MGI
  • increased papilloma incidence / MGI
  • abnormal tumor incidence / MGI
  • increased tumor incidence / MGI
  • increased B cell derived lymphoma incidence / MGI
  • increased T cell derived lymphoma incidence / MGI
  • increased sarcoma incidence / MGI
  • increased fibrohistocytoma incidence / MGI
  • increased carcinoma incidence / MGI
  • seizures / MGI
  • premature death / MGI
  • abnormal eye morphology / MGI
  • abnormal spleen red pulp morphology / MGI
  • abnormal sperm number / MGI
  • oligozoospermia / MGI
  • no phenotypic analysis / MGI
  • abnormal cell cycle / MGI
  • retinal detachment / MGI
  • testicular atrophy / MGI
  • abnormal lens capsule morphology / MGI
  • abnormal keratinocyte physiology / MGI
  • increased hemangiosarcoma incidence / MGI
  • increased tumor growth/size / MGI
  • abnormal retinal inner nuclear layer morphology / MGI
  • increased osteosarcoma incidence / MGI
  • increased squamous cell carcinoma incidence / MGI
  • increased incidence of tumors by chemical induction / MGI
  • increased incidence of tumors by ionizing radiation induction / MGI
  • decreased incidence of tumors by chemical induction / MGI
  • increased testis weight / MGI
  • decreased testis weight / MGI
  • increased thymus weight / MGI
  • increased double-positive T cell number / MGI
  • abnormal posterior eye segment morphology / MGI
  • abnormal retinal ganglion layer morphology / MGI
  • reproductive system phenotype / MGI
  • vision/eye phenotype / MGI
  • abnormal skin physiology / MGI
  • abnormal lens development / MGI
  • abnormal cell physiology / MGI
  • abnormal retinal neuronal layer morphology / MGI
  • binocular blindness / MGI
  • abnormal spermatocyte morphology / MGI
  • delayed cellular replicative senescence / MGI
  • increased CD4-positive, alpha beta T cell number / MGI
  • increased CD8-positive, alpha-beta T cell number / MGI
  • increased spleen white pulp amount / MGI
  • increased lung carcinoma incidence / MGI
  • increased brain tumor incidence / MGI
  • increased small lymphocytic lymphoma incidence / MGI
  • increased histiocytic sarcoma incidence / MGI
  • increased splenocyte proliferation / MGI
  • increased gastrointestinal stromal tumor incidence / MGI
  • primary vitreous hyperplasia / MGI
  • increased melanoma incidence / MGI
  • increased cutaneous melanoma incidence / MGI
  • increased acute lymphoblastic leukemia incidence / MGI
  • increased fibrosarcoma incidence / MGI
  • persistent hyperplastic primary vitreous / MGI
  • increased fibroblast proliferation / MGI
  • increased lymphoma incidence / MGI

Literature references

  • Loss of p16Ink4a confers susceptibility to metastatic melanoma in mice.;Krimpenfort P, Quon K C, Mooi W J, Loonstra A, Berns A, ;2001;Nature;413;83-6; 11544530
  • A Versatile ES Cell-Based Melanoma Mouse Modeling Platform.;Bok Ilah, Vera Olga, Xu Xiaonan, Jasani Neel, Nakamura Koji, Reff Jordan, Nenci Arianna, Gonzalez Jose G, Karreth Florian A, ;2020;Cancer research;80;912-921; 31744817

Information on how we integrate external resources can be found here

Order

Availabilities

Requesting frozen sperm or embryos is generally advisable wherever possible, in order to minimise the shipment of live mice.

  • Frozen sperm. Delivered in 4 weeks (after paperwork in place). €1740*
  • Rederivation of mice from frozen stock, delivery time available upon request . €3880*

Due to the dynamic nature of our processes strain availability may change at short notice. The local repository manager will advise you in these circumstances.

* In addition users have to cover all the shipping costs (including the cost for returning dry-shippers, where applicable).

More details on pricing and delivery times

Practical information

Genotyping protocol

Example health report
(Current health report will be provided later)

Material Transfer Agreement (MTA)
Distribution of this strain is subject to a provider MTA. Both signing of the MTA and submission of the online EMMA Mutant Request Form are required before material can be shipped.

EMMA conditions
Legally binding conditions for the transfer

Other EMMA strains

Not found what you were looking for? Search here for other strains available from EMMA.


Search
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).